Evidence map›Paper›PMID 29865239›Full record

ReviewMolecules (Basel, Switzerland)2018

Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.

Francesco Berti, Riccardo De Ricco, Rino Rappuoli

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. TheVaccines · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Impact of O-Acetylation onMicroorganisms · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Francesco BertiTechnical R&D, GSK Vaccines, 53100 Siena, Italy. francesco.x.berti@gsk.com.
Riccardo De RiccoPreclinical R&D, GSK Vaccines, 53100 Siena, Italy. riccardo.x.de-ricco@gsk.com.
Rino RappuoliExternal R&D, GSK Vaccines, 53100 Siena, Italy. rino.x.rappuoli@gsk.com.
Toscana Life Sciences · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of infectious diseases caused by several bacterial pathogens such as

Indexed as

AcetylationAntigens, BacterialBacterial VaccinesGlycoconjugatesHumansNeisseria meningitidis, Serogroup CPolysaccharides, BacterialSalmonella typhiStaphylococcus aureusStreptococcus pneumoniaeAntigens, BacterialBacterial VaccinesGlycoconjugatesPolysaccharides, Bacterialbacterial vaccinescarbohydrate antigensconjugate vaccinesO-acetylation

Identifiers

PMID29865239
PMCPMC6100563
OpenAlexW2805253599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.